AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330 | -34.3% | 725 | -3.2% | 0.00% | – |
| Q2 2023 | $502 | +59.4% | 749 | +2.3% | 0.00% | – |
| Q1 2023 | $315 | +38.8% | 732 | +0.7% | 0.00% | – |
| Q4 2022 | $227 | – | 727 | +1.1% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 719 | -93.3% | 0.00% | – |
| Q2 2022 | $8,000 | -27.3% | 10,722 | +4.2% | 0.00% | – |
| Q1 2022 | $11,000 | +10.0% | 10,286 | -12.8% | 0.00% | – |
| Q4 2021 | $10,000 | -54.5% | 11,794 | +9.3% | 0.00% | – |
| Q3 2021 | $22,000 | -4.3% | 10,793 | -0.1% | 0.00% | – |
| Q2 2021 | $23,000 | +155.6% | 10,809 | +187.1% | 0.00% | – |
| Q1 2021 | $9,000 | -87.7% | 3,765 | -90.7% | 0.00% | – |
| Q4 2020 | $73,000 | -20.7% | 40,560 | -5.1% | 0.00% | – |
| Q3 2020 | $92,000 | +1.1% | 42,738 | +15.3% | 0.00% | – |
| Q2 2020 | $91,000 | +2933.3% | 37,078 | +3414.5% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |